Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2016-A00366-45 | Other Identifier | ID-RCB number, ANSM |
Not provided
Not provided
sponsor decision
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Post-stroke patients often present with gait disorders due to several physical impairments. Hip flexor deficit is one of the more prevalent trouble and is associated with gait capacities. This study aims at evaluating the impact of an isokinetic hip flexors strengthening rehabilitation program in the subacute phase after stroke. Patients will be randomized to an intervention group (isokinetic rehabilitation) or a control group (conventional rehabilitation) and assessed at the end of the rehabilitation program, at 3 and at 6 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Isokinetic | Active Comparator | Patients who benefit from the hip flexors isokinetic strengthening rehabilitation program |
|
| Control | Active Comparator | Patients who benefit from a conventional rehabilitation program |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Isokinetic hip flexors strengthening | Procedure | Isokinetic excentric strengthening of paretic hip flexors, 3/w during 6 weeks, in addition to conventional rehabilitation 7/w. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Max gait speed (m/s) | Gait speed will be assessed in the 10m walk test | 6 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Max gait speed (m/s) | Gait speed will be assessed in the 10m walk test | 3 and 6 months |
| Hip flexors strength | Hip flexors strength will be evaluated using an isokinetic dynamometer (concentric, 30°/s) and motor testing (medical research council) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Etienne Allart, MD | University Hospital, Lille | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| D006429 | Hemiplegia |
| D010291 | Paresis |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Conventional rehabilitation | Procedure | Conventional rehabilitation 10/w during 6 weeks |
|
| 6weeks; 3 and 6 months |
| Gait endurance | Gait endurance will be assessed using the 6MWT | 6 weeks; 3 and 6 months |
| Gait capacities | Functional ambulation categories (FAC) | 6 weeks; 3 and 6 months |
| Balance and postural control | Postural Assessment for Stroke Scale (PASS) | 6 weeks; 3 and 6 months |
| Balance and postural control | Timed-up and go test | 6 weeks; 3 and 6 months |
| Rate of perceived exhaustion during gait | Borg scale | 6 weeks; 3 and 6 months |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D010243 | Paralysis |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |